B-cell Lymphoma Clinical Trials
3 recruiting trials for B-cell Lymphoma. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 2NCT06566586
A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the...
To evaluate the efficacy and safety of TQB3702 tablets combined with immunochemotherapy for the treatment of B-cell lymphoma
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Enrolling: 8020 locations
RECRUITINGPhase 1NCT05653271
ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies
ACE1831 is an off-the-shelf, allogeneic gamma delta T (gdT) cell therapy derived from healthy donors, that is under investigation for the treatment of CD20-expressing B-cell...
Sponsor: Acepodia Biotech, Inc.Enrolling: 4213 locations
RECRUITINGNCT06485076
Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma
Patients with multiple myeloma experience a wide range of physical and psychological symptoms from the time of their diagnosis. Meanwhile, patients with aggressive lymphomas...
Sponsor: University Health Network, TorontoEnrolling: 1441 location